Hematological Malignancy
Oncology·MeSH: Hematologic Neoplasms
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| ADI-270 | Adicet Bio, Inc. (ACET) |
Frequently asked questions
How many drugs are in development for Hematological Malignancy?
BioSniper tracks 1 drug in development for Hematological Malignancy across 1 company.
How many clinical trials target Hematological Malignancy?
There are 2 clinical trials targeting Hematological Malignancy tracked by BioSniper.
Deep-dive into Hematological Malignancy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis